The prognosis for brain cancer has not changed much over the last few decades, but researchers at The University of Kansas Cancer Center are working to change that. Dr. David Akhavan, radiation oncologist and physician-scientist, will share how immunotherapy for brain cancer is the next breakthrough in research. Also joining the conversation will be Matt Anthony, founder of Head for the Cure and a cancer survivor.

To make progress against cancer, we need everyone's help! Dr. Tara Lin, director of The University of Kansas Cancer Center's Clinical Trials Office and Cici Rojas, a cancer survivor who participated in a clinical trial and a leader in Kansas City's Latinx community, are joining Dr. Roy Jensen to talk about why diversity in clinical research is so important.

For many cancer patients and survivors, changes in appearance caused by treatments or surgery pose physical and emotional obstacles to recovery. An accredited cancer appearance center, Missys' Boutique® helps overcome these obstacles with spirit and style. Tune in to learn more about the boutique's mission to help cancer patients and survivors throughout the region restore their dignity, build their self-confidence and reclaim their self-image.

You may have heard us say, "where you get your mammogram matters." But do you know why? Hear breast radiologist Onalisa Winblad, MD, delve into why "where you get your mammogram" really does matter.

In honor of the 50th anniversary of the National Cancer Act, Dr. Norman Sharpless, director of the National Cancer Institute, and Dr. Henry Ciolino, director of the Office of NCI Cancer Centers, join Dr. Roy Jensen, vice chancellor and director of The University of Kansas Cancer Center, on a very special episode to discuss all things cancer research.

Study results show CAR T-cell therapy improves survival for adults with large B-cell lymphoma who did not respond well to or relapsed after, the first line of treatment. Learn about CAR T-cell therapy for large B-cell lymphoma from Dr. Joseph McGuirk, medical director of the blood and marrow transplant program at The University of Kansas Cancer Center.

18 months into a global pandemic, half of the United States has been vaccinated against COVID-19, but we are at the height of yet another surge as the highly contagious Delta variant rages. Dr. Wejing Sun, director of Medical Oncology and associate director for clinical research at The University of Kansas Cancer Center, explains how we care for one of our most vulnerable populations, our cancer patients, who are uniquely susceptible to this deadly infectious disease.

Dr. Roy Jensen, director of The University of Kansas Cancer Center, talks with Annie Seal, children's program director at Turning Point, and Laura Frees, co-survivor and member of Patient and Investigator Voices Organizing Together (PIVOT), on how to talk to children about a loved one's cancer diagnosis.

Experts discuss the progress we are making toward being able to provide proton therapy for our patients. Proton therapy is the most technologically advanced method to deliver radiation treatment to cancerous tumors available today.